Lethal adulthood myelin breakdown by oligodendrocyte-specific Ddx54 knockout

Hiroaki Oizumi1, Yuki Miyamoto2,3, Chika Seiwa4

  • 1Tsumura Kampo Laboratories, Tsumura & Co, Ami, Ibaraki 300-1192, Japan.

Iscience
|September 18, 2023
PubMed

Insights

The DEAD-box RNA helicase Ddx54 is crucial for maintaining myelin integrity in the central nervous system. Its absence leads to progressive demyelination and neurological deficits, offering a new model for studying myelin disorders.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Multiple sclerosis (MS) is a significant cause of disability in young adults, characterized by myelin damage.
  • Previous research identified DEAD-box RNA helicase Ddx54's role in binding myelin basic protein (MBP) mRNA and protein isoforms.
  • Ddx54 knockdown was previously shown to impair oligodendrocyte migration and myelination.

Purpose of the Study:

  • To investigate the in vivo function of Ddx54 in adult myelin maintenance.
  • To establish a novel animal model for studying intrinsic myelin disintegration and demyelinating diseases.

Main Methods:

  • Generation and analysis of MBP-driven Ddx54 knockout mice (Ddx54 fl/fl;MBP-Cre).
  • Assessment of behavioral profiles, learning ability, and histological examination of the central nervous system.
  • Evaluation of myelin vulnerability using the neurotoxicant cuprizone and in vitro Ddx54 knockdown experiments.

Main Results:

  • Ddx54 knockout mice exhibit progressive behavioral and learning deficits, inner myelin sheath breakdown, axon loss, and oligodendrocyte apoptosis.
  • These mice show increased susceptibility to cuprizone-induced demyelination and reduced myelination upon Ddx54 knockdown in vitro.
  • Reduced Ddx54 expression was observed in oligodendrocyte-lineage cells in the corpus callosum of MS patients.

Conclusions:

  • Ddx54 is essential for maintaining myelin homeostasis in the adult central nervous system.
  • The Ddx54 knockout mouse model recapitulates key features of intrinsic myelin disintegration.
  • These findings highlight Ddx54 as a potential therapeutic target for demyelinating diseases like MS.